Compliance with Public Health Measures and Psychological Effects of COVID-19: Two-Group Cross-Sectional Research

Year 2022, Volume: 12 Issue: 2, 302 - 309, 30.06.2022

Tahsin Şimşek Aynur Kaynar Şimşek

https://doi.org/10.33808/clinexphealthsci.1007635

Abstract

Objective: COVID-19 has spread since the day it emerged and was declared as a global pandemic. Determining the psychological effects of this situation and the compliance with public health measures will be a guide both in the fight against the COVID-19 pandemic and possible epidemics in the future. This two-group, cross-sectional descriptive study aimed to determine compliance with public health measures against COVID-19 and to evaluate the levels of fear, depression, anxiety, and stress by analysing individuals who experienced and did not experience COVID-19.
Method: The study sample consisted of a total of 636 participants. Of these participants, 328 had a positive Polymerase Chain Reaction test and 308 had a negative test. Data was collected using the Diagnostic Form, Questionnaire for the Compliance with Public Health Measures Against the COVID-19, Fear of COVID-19 Scale, and the Short Form Depression Anxiety Stress Scale in our online database.
Results: Although the participants’ compliance with public health measures regarding the use of masks is high, their compliance with the measures related to physical distance is low. Moreover, fear of COVID-19, anxiety, stress, and depression levels are higher in individuals who experienced COVID-19 than those who did not experience COVID-19. Also, both groups have high levels of fear, anxiety, stress, and depression.
Conclusion: In conclusion, priority should be given to strategies aimed to increase compliance with physical distance and to detect and control the psychological effects of COVID-19 in the whole society, especially in individuals experiencing COVID-19.

Keywords

COVID-19, public health measures, compliance, psychological effects

References

• [1]Basile C, Combe C, İzzarelli F, Covic A, Davenport A, Kanbay M, Kirmizis D, Schneditz D, Sande FVD, Mitra S. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant 2020;35(5):737-741.
• [2] Ciyiltepe F, Saracoglu A, Kahraman E, Bilir Y, Bombacı E, Saracoglu KT. The effect of extended hydroxychloroquine in intensive care management of Covid-19 on survival and costs. Kocaeli Med J. 2020;9(3):128-135.
• [3] World Health Organization. WHO Coronavirus (COVID-19) Dashboard 2020. Available from: https://covid19.who.int/
• [4] Morawska L, Cao J. Airborne transmission of SARS-CoV-2: the world should face the reality. Environ Int. 2020;139:105730.
• [5] Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment Coronavirus (COVID-19) 2022. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/32150360.
• [6] Wu P, Fang Y, Guan Z, Fan B, Kong J, Yao Z, Liu X, Fuller CJ, Susser E, Lu J, Hoven CW. The psychological impact of the SARS epidemic on hospital employees in China: Exposure, risk perception, and altruistic acceptance of risk. Canadian Journal of Psychiatry 2009;54(5):302–311.
• [7] Wax RS, Randy S, Christian MD. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Canadian Journal of Anesthesia 2020: 67(5):568-576
• [8] Yan Y, Chen H, Chen l, Cheng B, Diao P, Dong l, Gao X, Gu H, He L, Ji C, Jin H, Lai W, Lei T, Li L, Li L, Li R, Liu D, Liu W, Lu Q, Shi Y, Song J, Tao J, Wang B, Wang G, Wu Y, Xiang L, Xie J, Xu J, Yao Z, Zhang F, Zhang J, Zhong S, Li H, Li H. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease. Dermatologic Therapy 2020;33(4):e13310.
• [9] World Health Organization. Taxonomy and glossary of public health and social measures that may be implemented to limit the spread of Covid-19 2020. Available from: https://www. who.int/emergencies/diseases/novel-coronavirus-2019/phsm
• [10] World Health Organization. COVID-19 Vaccines 2021. Available from: https://www.who.int/emergencies/diseases/novel- coronavirus-2019/covid-19-vaccines
• [11] World Health Organization. Behavioural considerations for acceptance and uptake of COVID-19 vaccines 2020. Available from: https://www.who.int/publications/i/ item/978.924.0016927
• [12] Rubin GJ, Wessely S. The psychological effects of quarantining a city. Bmj 2020 ;368:m313
• [13] Esterwood E, Saeed A. Past epidemics, natural disasters, COVID19, and mental health: Learning from history as we deal with the present and prepare for the future. Psychiatric Quarterly, 2020; 91(4):1121–1133.
• [14] The psychological impact of epidemic and pandemic outbreaks on healthcare workers: Rapid review of the evidence. Current Psychiatry Reports 2020;22(8):43
• [15] Saracoglu KT, Simsek T, Kahraman S, Bombaci E, Sezen Ö, Saracoglu A, Demirhan R. The psychological impact of COVID-19 disease is more severe on intensive care unit healthcare providers: A cross-sectional Study. Clin Psychopharmacol Neurosci. 2020;18(4): 607-615.
• [16] Yılmaz Ö, Boz H, Arslan A. The validity and reliability of depression stress and anxiety scale (DASS-21) Turkish short form. Research of Financial Economic and Social Studies 2017;2(2):78-91.
• [17] Zhanga J, Lua H, Zengb H, Zhangb S, Dua Q, Jianga T, Du B. The differential psychological distress of populations affected by the COVID-19 pandemic. Brain, Behavior, and Immunity 2020;87:49–50.
• [18] World Health Organization. Coronavirus disease (COVID-19) 2020. Available from: https://www.who.int/docs/default- source/coronaviruse/situation-reports/20200805-covid-19- sitrep-198.pdf?sfvrsn=f99d1754_2
• [19] Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: Development and initial validation. International Journal of Mental Health and Addiction.2020;1-9.
• [20] Bakioğlu F, Korkmaz O, Ercan H. Fear of COVID-19 and positivity: Mediating role of intolerance of uncertainty, depression, anxiety, and stress. International Journal of Mental Health and Addiction, 2020;1-14.
• [21] Lovibond SH, Lovibond PF. The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behaviour Research and Therapy 1995;33(3):335-343
• [22] Brown TA, Chorpita BF, Korotitsch W, Barlow DH. Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behaviour Research and Therapy 1997;35(1):79-89.
• [23] Jayaweera M, Pererab H, Gunawardana B, Manatunge j. Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environmental Research 2020;188:109819
• [24] Kucharski AJ, Klepac P, Conlan AJK, Kissler SM, Tang ML, Fry H, Gog JR, Edmunds WJ. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis.2020;20(10):1151-1160.
• [25] Lessa JPA, Hofstatter LM, Carvalho LF. Cognitive abilities and probabilities of adherence to containment measures against the COVID-19 pandemic. Braz J Psychiatry 2021;43(4): 447- 448.
• [26] Mertens G, Gerritsen L, Duijndam S, Salemink E, Engelhard IM. Fear of the coronavirus (COVID-19): Predictors in an online study conducted in March 2020. Journal of Anxiety Disorders 2020;74:102258.
• [27] Asmundson GJ, Abramowitz JS, Richter AA, Whedon M. Health anxiety: Current perspectives and future directions. Curr Psychiatry Rep 2010;12(4):306-312.
• [28] Brand J, McKay D, Wheaton MG, Abramowitz JS. The relationship between obsessive compulsive beliefs and symptoms, anxiety and disgust sensitivity, and Swine Flu fears. J Obsessive Compuls Relat Disord. 2013;2(2):200-206
• [29] Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1789-1858
• [30] Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, Bruffaerts R, Girolamo GD, Graaf RD, Gureje O, Haro JM, Karam EG, Kessler RC, Kovess V, Lane MC, Lee S, Levinson D, Ono Y, Petukhova M, Villa JP, Seedat S, Wells JE. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 2007;370(9590):841-50
• [31] Correa VP, Confortin SC, d’Orsi E, de Sa ́-Junior AR, de Oliveira C, Schneider IJC. Depressive symptoms as an independent risk factor for mortality. Braz J Psychiatry 2021;43(3):247-253